Skip to content
Clinical Trials – home

Traumatologijas Un Ortopedijas Slimnica SIA

Research site

Latvia Duntes Iela 22, 1005 Riga, Latvia

  • 1 trial recruiting
  • Embolism · Embolism venous
  • Adult patients

About Specializations

Traumatologijas Un Ortopedijas Slimnica SIA in Riga, Latvia specialises in clinical trials of conditions such as Embolism, Embolism venous, and other specialisations. This site conducts important research.

Main research areas of the site

Thromboembolic Disease

The medical center is at the forefront of research in thromboembolic disease, focusing on innovative approaches to prevent and manage blood clots. This area of study is crucial for patients undergoing surgical procedures, such as knee replacements, where the risk of clot formation is significant.

  • Prevention of Venous Thromboembolism (VTE)
  • Post-Surgical Thrombosis Management
  • Comparative Efficacy of Anticoagulants

Through ongoing trials, the center is evaluating the effectiveness of new therapeutic agents like REGN7508 in comparison to established treatments, aiming to enhance patient outcomes and reduce the incidence of post-operative complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Duntes Iela 221005 RigaLatvia
Recruiting now
1 trial
Conditions studied
2

More sites in RigaLatvia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Embolism

Recruiting

Comparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery

Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Embolism venous

Not recruiting

Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Sirius Therapeutics Inc.

Embolism

Not recruiting

Study on REGN7508 for Preventing Blood Clots in Adults After Knee Replacement Surgery

Registered drugNo placebo
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Regeneron Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.